Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
Mounjaro (Tirzepatide) Cost: 2026 Price, Savings & Coverage
articlePrescribed Mounjaro for type 2 diabetes and wondering what it will actually cost? This guide covers every pricing tier specific to T2D patients: list price, savings card, Medicare Part D coverage, prior authorisation, and the cheapest legitimate cash-pay route.
Tirzepatide Cost in 2026: Brand, Vials, and Insurance Guide
articleTirzepatide list price runs over $1,000/month—but what you actually pay can be far less. This guide covers every pricing tier: Mounjaro and Zepbound pens, LillyDirect self-pay vials, insurance and savings cards, Medicare, and where compounded tirzepatide stands after the FDA's 2025 ruling. Includes a cost-per-mg breakdown tied to dose optimisation.